TipRanks
BeOne Medicines (MX:ONCN)
:ONCN
Mexico Market
ONCN
BeOne Medicines
RESEARCH TOOLSreports

BeOne Medicines (ONCN) Stock News & Sentiment

0 Followers
BeOne Medicines Advances BG-85738 Into First-in-Human RAS Cancer Trial
Premium
Company Announcements
BeOne Medicines Advances BG-85738 Into First-in-Human RAS Cancer Trial
8d ago
ONC
BeiGene Wraps Key Drug Interaction Study for BGB-16673, Sharpening Oncology Pipeline Outlook
Premium
Company Announcements
BeiGene Wraps Key Drug Interaction Study for BGB-16673, Sharpening Oncology Pipeline Outlook
26d ago
ONC
Early-Stage HH160 Cancer Trial Puts BeOne Medicines on Long-Term Investors’ Radar
Premium
Company Announcements
Early-Stage HH160 Cancer Trial Puts BeOne Medicines on Long-Term Investors’ Radar
29d ago
ONC
BeOne Medicines Takes Aim at Hard-To-Treat Childhood Leukemia With New Sonrotoclax Trial
Premium
Company Announcements
BeOne Medicines Takes Aim at Hard-To-Treat Childhood Leukemia With New Sonrotoclax Trial
1M ago
ONC
BeOne Medicines Earnings Call Signals Robust Growth
Premium
Company Announcements
BeOne Medicines Earnings Call Signals Robust Growth
1M ago
ONC
Subcutaneous Tislelizumab Trial Completion Signals Next Steps for BeOne Medicines and BeiGene
Premium
Company Announcements
Subcutaneous Tislelizumab Trial Completion Signals Next Steps for BeOne Medicines and BeiGene
1M ago
ONC
Analyst Lifts BeOne Medicines Price Target to $466 on Robust BRUKINSA Growth and Pipeline Milestones
Premium
Ratings
Analyst Lifts BeOne Medicines Price Target to $466 on Robust BRUKINSA Growth and Pipeline Milestones
1M ago
ONC
More MX:ONCN News >

ONCN News on the Web

BeOne Medicines AG at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Goldman picks China healthcare stocks for a post-AI trade
CNBC
Neutral
DBS Keeps Their Hold Rating on BeOne Medicines Ltd (6160)
TipRanks News
Bullish
BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?
Insider Monkey
Neutral
Top BeOne Medicines Executive Makes Eye-Catching Stock Move
TipRanks News
Bullish
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
Zacks
Neutral
BeOne Medicines to expand access to cancer medicines under pact with U.S.
TipRanks News
Bullish
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MX:ONCN
Sector Average
Media Buzz
This Week1 articles
Weekly Average5.25 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:ONCN’s Media Buzz Sentiment?
1 articles about MX:ONCN were published this week. In an average week, 5.25 articles are published.
    What is MX:ONCN’s weekly average amount of articles?
    In an average week, 5.25 articles about MX:ONCN are published.
      What is MX:ONCN’s News Sentiment?
      50% of articles about MX:ONCN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CRLCharles River Labs
        DFTXDefinium Therapeutics
        AMRXAmneal Pharmaceuticals
        SMMTSummit Therapeutics
        ABEOAbeona Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week